CNS Pharmaceuticals raises ~$5.0M in public offering of stock and warrants

CNS Pharmaceuticals, Inc.

Offering of 325,000 shares, 3,627,570 pre-funded warrants, and 3,952,570 common warrants.
Combined purchase price: $1.265 per share+common warrant, $1.264 per pre-funded+common warrant.
Gross proceeds ~$5.0M; net proceeds for working capital and general corporate purposes.
Common warrants exercisable at $1.14 for 5 years; pre-funded warrants at $0.001.
Company agreed to 45-day no-issuance and 180-day no variable-rate transaction lock-up.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.